Seminars in Arthritis and Rheumatism
Volume 40, Issue 4 , Pages 343-348, February 2011

Neuromyelitis Optica Spectrum Disorder as an Initial Presentation of Primary Sjögren's Syndrome

  • J. Michelle Kahlenberg, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to J. Michelle Kahlenberg MD, PhD, Division of Rheumatology, University of Michigan Health System, 3918 Taubman Center, 1500 E. Medical Center Drive, SPC 5358, Ann Arbor, MI 48109-5358

Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI

published online 23 July 2010.

Objectives

Longitudinal myelitis in patients with Sjögren's syndrome (SS) is a rarely reported occurrence. Here, we present a patient with longitudinal myelitis who was found to have both primary SS and a positive antibody to aquaporin-4 (NMO-IgG). We review the recent literature concerning the overlap between primary SS-associated myelitis and the presence of NMO-IgG, suggestive of a neuromyelitis optica spectrum disorder (NMOSD).

Methods

A patient with longitudinal myelitis, SS, and a positive NMO-IgG is presented. A review of the relevant English literature based on a PubMed and Embase search is then discussed. The keywords used were Sjögren's syndrome, myelitis (longitudinal and transverse), neuromyelitis optica, and Devic's disease.

Results

Our patient fulfills the criteria for both primary SS and NMOSD. Several small studies have shown that most SS patients with longitudinal myelitis are positive for the antibody to aquaporin-4. Additionally, minor salivary gland biopsies of patients with NMO or NMOSD have evidence of lymphocytic inflammation, suggesting that there may be an overlap in the mechanism of NMOSD and longitudinal myelitis secondary to primary SS. This overlap in mechanism may have important ramifications with regard to prognosis and treatment of SS-related myelitis.

Conclusion

The presentation of longitudinal myelitis in a patient with SS should be considered a possible NMOSD. Checking for the presence antiaquaporin-4 antibodies provides important prognostic information and may help to guide treatment decisions.

Keywords: Sjogren's syndrome, myelitis, neuromyelitis optica, Devic's disease, NMO, aquaporin-4

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Sources of Support: Division of Rheumatology, Department of Internal Medicine, University of Michigan.

 The author has no conflicts of interest to disclose.

PII: S0049-0172(10)00080-6

doi:10.1016/j.semarthrit.2010.05.005

Seminars in Arthritis and Rheumatism
Volume 40, Issue 4 , Pages 343-348, February 2011